Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$151.44 - $200.09 $170,370 - $225,101
1,125 New
1,125 $222,000
Q4 2022

Jan 10, 2023

BUY
$131.14 - $157.47 $147,532 - $177,153
1,125 New
1,125 $0
Q2 2022

Aug 04, 2022

SELL
$155.97 - $200.09 $241,753 - $310,139
-1,550 Closed
0 $0
Q1 2022

Apr 28, 2022

BUY
$181.39 - $234.03 $281,154 - $362,746
1,550 New
1,550 $292,000
Q3 2021

Oct 14, 2021

SELL
$189.29 - $209.69 $823,411 - $912,151
-4,350 Closed
0 $0
Q3 2020

Oct 08, 2020

BUY
$137.1 - $165.37 $596,385 - $719,359
4,350 New
4,350 $719,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Madden Securities Corp Portfolio

Follow Madden Securities Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madden Securities Corp, based on Form 13F filings with the SEC.

News

Stay updated on Madden Securities Corp with notifications on news.